2009

Medisse announces closure of a financing round by BioGeneration Ventures and Crédit Agricole Private Equity - 10 December 2009

Mucosis receives key US patent covering its Mimopath (tm) Technology - 22 September 2009

arGEN-X raises €9.5 million to put SIMPLE Antibody™ platform to work - 10 September 2009

FlexGen announced today the closure of an equity financing round by BioGeneration Ventures and Crédit Agricole Private Equity - 2 March 2009

DSM and Crucell Sign Agreement with Bioceros ... - 10 February 2009

Mucosis B.V. and PATH start development of pneumococcal vaccines - 28 January 2009

Progentix Orthobiology and NuVasive Sign Investment Agreement - 14 January 2009

NuVasive Announces Investment in Novel Orthobiologic Company - 13 January 2009

2008

Mucosis B.V. and TNO announce flu vaccine research and development partnership - 15 December 2008

Mucosis B.V. appoints Dr. Govert Schouten as CEO - 6 November 2008

Bioceros B.V. closes first financing round - 21 September 2008

Progentix Orthobiology B.V. closes Series A financing round - 21 January 2008

NovioGendix closes Series A Financing Round - 21 January 2008

2007

Mucosis raises € 3 million in first financing round - 10 September 2007

Forbion Capital Partners spins out of ABN AMRO Capital - 08 January 2007

2006

First closing of BioGeneration Ventures Fund - 17 November 2006